This Is Why Moderna May Crush Its Vaccine Rivals
28/2 12:00
Moderna (NASDAQ: MRNA) has established itself as a coronavirus vaccine leader. But the company also aims to take significant market share in the prevention of other respiratory diseases. And one of those areas is overflowing with competition. I'm talking about the flu vaccine mar...